The global Circulating Tumor Cell Diagnosis market size is estimated at 26.9 billion USD with a CAGR of 12.9% during the forecasted period from 2021-2028.
Table of Contents 1 Circulating Tumor Cell Diagnostics Market Overview 1.1 Product Overview and Scope of Circulating Tumor Cell Diagnostics 1.2 Circulating Tumor Cell Diagnostics Segment by Types 1.2.1 Global Circulating Tumor Cell Diagnostics Sales Growth Rate Comparison by Types (2014-2025) 1.2.2 CTC Enrichment 1.2.3 CTC Detection 1.2.4 CTC Analysis 1.3 Circulating Tumor Cell Diagnostics Segment by Applications 1.3.1 Global Circulating Tumor Cell Diagnostics Sales Comparison by Applications (2014-2025) 1.3.2 Tumorigenesis Research 1.3.3 EMT Biomarkers Development 1.3.4 Cancer Stem Cell Research 1.3.5 Others 1.4 Global Circulating Tumor Cell Diagnostics Market by Regions 1.4.1 Global Circulating Tumor Cell Diagnostics Market Size by Regions 1.4.2 North America Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025) 1.4.3 Europe Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025) 1.4.4 China Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025) 1.4.5 Japan Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025) 1.5 Global Circulating Tumor Cell Diagnostics Market Size 1.5.1 Global Circulating Tumor Cell Diagnostics Revenue (2014-2025) 1.5.2 Global Circulating Tumor Cell Diagnostics Sales (2014-2025) 2 Global Circulating Tumor Cell Diagnostics Market Competition by Manufacturers 2.1 Global Circulating Tumor Cell Diagnostics Sales Market Share by Manufacturers (2014-2019) 2.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Manufacturers (2014-2019) 2.3 Global Circulating Tumor Cell Diagnostics Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Circulating Tumor Cell Diagnostics Manufacturing Sites, Area Served, Product Types 2.5 Circulating Tumor Cell Diagnostics Market Competitive Situation and Trends 2.5.1 Circulating Tumor Cell Diagnostics Market Concentration Rate 2.5.2 Circulating Tumor Cell Diagnostics Market Share of Top 5 and Top 10 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Circulating Tumor Cell Diagnostics Sales by Regions (2014-2019) 3.1 Global Circulating Tumor Cell Diagnostics Sales Market Share by Regions 3.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions (2014-2019) 3.3 Global Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 3.4 North America Circulating Tumor Cell Diagnostics Sales 3.4.1 North America Circulating Tumor Cell Diagnostics Sales Growth Rate (2014-2019) 3.4.2 North America Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 3.5 Europe Circulating Tumor Cell Diagnostics Sales 3.5.1 Europe Circulating Tumor Cell Diagnostics Sales Growth Rate (2014-2019) 3.5.2 Europe Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 3.6 China Circulating Tumor Cell Diagnostics Sales (2014-2019) 3.6.1 China Circulating Tumor Cell Diagnostics Sales Growth Rate (2014-2019) 3.6.2 China Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 3.7 Japan Circulating Tumor Cell Diagnostics Sales (2014-2019) 3.7.1 Japan Circulating Tumor Cell Diagnostics Sales Growth Rate (2014-2019) 3.7.2 Japan Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 4 Global Circulating Tumor Cell Diagnostics Sales, Revenue, Price Trend by Types 4.1 Global Circulating Tumor Cell Diagnostics Sales Market Share by Types (2014-2019) 4.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Types (2014-2019) 4.3 Global Circulating Tumor Cell Diagnostics Price by Type (2014-2019) 4.4 Global Circulating Tumor Cell Diagnostics Sales Growth by Type (2014-2019) 5 Global Circulating Tumor Cell Diagnostics Market Analysis by Applications 5.1 Global Circulating Tumor Cell Diagnostics Sales Market Share by Applications (2014-2019) 5.2 Global Circulating Tumor Cell Diagnostics Consumption Growth Rate by Applications (2014-2019) 6 Company Profiles and Key Figures in Circulating Tumor Cell Diagnostics Business 6.1 Janssen Diagnostics 6.1.1 Janssen Diagnostics Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.1.2 Janssen Diagnostics Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.1.4 Janssen Diagnostics Main Business and Markets Served 6.2 Advanced Cell Diagnostics 6.2.1 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.2.2 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.2.4 Advanced Cell Diagnostics Main Business and Markets Served 6.3 Aviva Biosciences 6.3.1 Aviva Biosciences Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.3.2 Aviva Biosciences Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.3.4 Aviva Biosciences Main Business and Markets Served 6.4 Biocept Inc 6.4.1 Biocept Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.4.2 Biocept Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.4.4 Biocept Inc Main Business and Markets Served 6.5 Biofluidica, Inc. 6.5.1 Biofluidica, Inc. Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.5.2 Biofluidica, Inc. Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.5.3 Biofluidica, Inc. Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.5.4 Biofluidica, Inc. Main Business and Markets Served 6.6 CellTraffix, Inc. 6.6.1 CellTraffix, Inc. Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.6.2 CellTraffix Inc. Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.6.3 CellTraffi, Inc. Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.6.4 CellTraffix, Inc. Main Business and Markets Served 6.7 Clearbridge BioMedics Pte Ltd 6.7.1 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.7.2 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.7.4 Clearbridge BioMedics Pte Ltd Main Business and Markets Served 6.8 Epic Sciences Inc. 6.8.1 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.8.2 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.8.4 Epic Sciences Inc. Main Business and Markets Served 6.9 Fluxion Biosciences Inc. 6.9.1 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.9.2 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.9.4 Fluxion Biosciences Inc. Main Business and Markets Served 6.10 ScreenCell 6.10.1 ScreenCell Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.10.2 ScreenCell Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.10.3 ScreenCell Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.10.4 ScreenCell Main Business and Markets Served 6.11 Silicon Biosystems 6.11.1 Silicon Biosystems Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.11.2 Silicon Biosystems Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.11.4 Silicon Biosystems Main Business and Markets Served 6.12 Sysmex Corporation 6.12.1 Sysmex Corporation Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.12.2 Sysmex Corporation Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.12.4 Sysmex Corporation Main Business and Markets Served 6.13 Greiner Bio-One GmbH 6.13.1 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.13.2 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.13.4 Greiner Bio-One GmbH Main Business and Markets Served 6.14 AdnaGen AG 6.14.1 AdnaGen AG Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.14.2 AdnaGen AG Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.14.4 AdnaGen AG Main Business and Markets Served 6.15 Apocell Inc 6.15.1 Apocell Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.15.2 Apocell Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.15.4 Apocell Inc Main Business and Markets Served 6.16 Biocep Ltd 6.16.1 Biocep Ltd Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.16.2 Biocep Ltd Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.16.4 Biocep Ltd Main Business and Markets Served 6.17 Canopus Bioscience Ltd 6.17.1 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.17.2 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.17.4 Canopus Bioscience Ltd Main Business and Markets Served 6.18 Creatv Microtech Inc 6.18.1 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.18.2 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.18.4 Creatv Microtech Inc Main Business and Markets Served 6.19 Ikonisys Inc 6.19.1 Ikonisys Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.19.2 Ikonisys Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.19.4 Ikonisys Inc Main Business and Markets Served 6.20 IV Diagnostics Inc 6.20.1 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.20.2 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.20.4 IV Diagnostics Inc Main Business and Markets Served 6.21 Miltenyi Biotech GmbH 6.21.1 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.21.2 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.21.4 Miltenyi Biotech GmbH Main Business and Markets Served 6.22 Nanostring Technologies Inc 6.22.1 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.22.2 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.22.4 Nanostring Technologies Inc Main Business and Markets Served 6.23 Rarecells Diagnostics. 6.23.1 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.23.2 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.23.4 Rarecells Diagnostics. Main Business and Markets Served 6.24 Vitatex Inc 6.24.1 Vitatex Inc Circulating Tumor Cell Diagnostics Manufacturing Sites and Area Served 6.24.2 Vitatex Inc Circulating Tumor Cell Diagnostics Product Introduction, Application and Specification 6.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Sales and Revenue (2014-2019) 6.24.4 Vitatex Inc Main Business and Markets Served 7 Circulating Tumor Cell Diagnostics Manufacturing Cost Analysis 7.1 Circulating Tumor Cell Diagnostics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Circulating Tumor Cell Diagnostics 7.4 Circulating Tumor Cell Diagnostics Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Circulating Tumor Cell Diagnostics Distributors List 8.3 Circulating Tumor Cell Diagnostics Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.4 Challenges 9.4 Porter's Five Forces Analysis 10 Global Circulating Tumor Cell Diagnostics Market Forecast 10.1 Global Circulating Tumor Cell Diagnostics Sales, Revenue Forecast 10.1.1 Global Circulating Tumor Cell Diagnostics Sales Growth Rate Forecast (2019-2025) 10.1.2 Global Circulating Tumor Cell Diagnostics Revenue and Growth Rate Forecast (2019-2025) 10.1.3 Global Circulating Tumor Cell Diagnostics Price and Trend Forecast (2019-2025) 10.2 Global Circulating Tumor Cell Diagnostics Sales Forecast by Regions (2019-2025) 10.2.1 North America Circulating Tumor Cell Diagnostics Sales, Revenue Forecast (2019-2025) 10.2.2 Europe Circulating Tumor Cell Diagnostics Sales, Revenue Forecast (2019-2025) 10.2.3 China Circulating Tumor Cell Diagnostics Sales, Revenue Forecast (2019-2025) 10.2.4 Japan Circulating Tumor Cell Diagnostics Sales, Revenue Forecast (2019-2025) 10.3 Global Circulating Tumor Cell Diagnostics Sales, Revenue and Price Forecast by Type (2019-2025) 10.4 Global Circulating Tumor Cell Diagnostics Consumption Forecast by Application (2019-2025) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer